Here is the latest financial fact sheet of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE quarterly results and STRIDES PHARMA SCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.9 |
No. of shares | m | 91.90 |
1 Week | % | 5.3 |
1 Month | % | 14.2 |
1 Year | % | 161.9 |
52 week H/L | Rs | 903.8/325.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
STRIDES PHARMA SCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 720 | 547 | 1,000 | 947 | 392 | |
Low | Rs | 334 | 271 | 304 | 305 | 263 | |
Sales per share (Unadj.) | Rs | 243.2 | 307.2 | 369.7 | 341.9 | 408.5 | |
Earnings per share (Unadj.) | Rs | 10.0 | 4.8 | 27.2 | -52.8 | -25.6 | |
Diluted earnings per share | Rs | 9.7 | 4.7 | 26.5 | -51.6 | -25.1 | |
Cash flow per share (Unadj.) | Rs | 23.1 | 24.2 | 50.2 | -26.9 | 1.4 | |
Dividends per share (Unadj.) | Rs | 3.00 | 14.00 | 2.50 | 0 | 1.50 | |
Adj. dividends per share | Rs | 2.92 | 13.65 | 2.44 | 0.00 | 1.47 | |
Avg Dividend yield | % | 0.6 | 3.4 | 0.4 | 0 | 0.5 | |
Book value per share (Unadj.) | Rs | 294.9 | 281.5 | 309.1 | 262.5 | 242.8 | |
Adj. book value per share | Rs | 287.4 | 274.4 | 301.6 | 256.5 | 238.6 | |
Shares outstanding (eoy) | m | 89.57 | 89.57 | 89.68 | 89.79 | 90.30 | |
Price / Sales ratio | x | 2.2 | 1.3 | 1.8 | 1.8 | 0.8 | |
Avg P/E ratio | x | 52.9 | 84.5 | 24.0 | -11.8 | -12.8 | |
P/CF ratio (eoy) | x | 22.8 | 16.9 | 13.0 | -23.3 | 239.6 | |
Price / Book Value ratio | x | 1.8 | 1.5 | 2.1 | 2.4 | 1.4 | |
Dividend payout | % | 30.1 | 289.2 | 9.2 | 0 | -5.9 | |
Avg Mkt Cap | Rs m | 47,194 | 36,648 | 58,465 | 56,177 | 29,603 | |
Total wages/salary | Rs m | 3,294 | 4,426 | 5,501 | 6,469 | 7,320 |
STRIDES PHARMA SCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 21,784 | 27,520 | 33,159 | 30,703 | 36,884 | |
Other income | Rs m | 408 | 531 | 594 | 1,334 | 1,352 | |
Total revenues | Rs m | 22,192 | 28,051 | 33,753 | 32,036 | 38,236 | |
Gross profit | Rs m | 2,182 | 3,310 | 5,723 | -3,762 | 830 | |
Depreciation | Rs m | 1,174 | 1,737 | 2,063 | 2,330 | 2,433 | |
Interest | Rs m | 793 | 1,557 | 1,501 | 1,767 | 2,611 | |
Profit before tax | Rs m | 624 | 547 | 2,754 | -6,525 | -2,862 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -269 | 113 | 317 | -1,783 | -553 | |
Profit after tax | Rs m | 893 | 434 | 2,438 | -4,743 | -2,309 | |
Gross profit margin | % | 10.0 | 12.0 | 17.3 | -12.3 | 2.2 | |
Effective tax rate | % | -43.0 | 20.7 | 11.5 | 27.3 | 19.3 | |
Net profit margin | % | 4.1 | 1.6 | 7.4 | -15.4 | -6.3 |
STRIDES PHARMA SCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 30,487 | 23,706 | 28,172 | 33,618 | 31,353 | |
Current liabilities | Rs m | 26,622 | 25,449 | 27,383 | 34,117 | 29,902 | |
Net working cap to sales | % | 17.7 | -6.3 | 2.4 | -1.6 | 3.9 | |
Current ratio | x | 1.1 | 0.9 | 1.0 | 1.0 | 1.0 | |
Inventory Days | Days | 158 | 158 | 158 | 90 | 71 | |
Debtors Days | Days | 165 | 124 | 122 | 144 | 129 | |
Net fixed assets | Rs m | 47,581 | 35,810 | 39,996 | 33,989 | 31,300 | |
Share capital | Rs m | 895 | 896 | 897 | 898 | 903 | |
"Free" reserves | Rs m | 25,516 | 24,321 | 26,823 | 22,670 | 21,025 | |
Net worth | Rs m | 26,411 | 25,217 | 27,719 | 23,568 | 21,928 | |
Long term debt | Rs m | 18,065 | 6,039 | 8,826 | 8,356 | 11,398 | |
Total assets | Rs m | 78,068 | 59,532 | 68,168 | 67,607 | 63,734 | |
Interest coverage | x | 1.8 | 1.4 | 2.8 | -2.7 | -0.1 | |
Debt to equity ratio | x | 0.7 | 0.2 | 0.3 | 0.4 | 0.5 | |
Sales to assets ratio | x | 0.3 | 0.5 | 0.5 | 0.5 | 0.6 | |
Return on assets | % | 2.2 | 3.3 | 5.8 | -4.4 | 0.5 | |
Return on equity | % | 3.4 | 1.7 | 8.8 | -20.1 | -10.5 | |
Return on capital | % | 3.2 | 6.7 | 11.6 | -14.9 | -0.8 | |
Exports to sales | % | 58.3 | 53.4 | 51.1 | 60.7 | 46.7 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 12,708 | 14,694 | 16,941 | 18,639 | 17,213 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 14,630 | 16,351 | 18,143 | 19,390 | 18,113 | |
Fx outflow | Rs m | 427 | 352 | 392 | 529 | 672 | |
Net fx | Rs m | 14,203 | 15,999 | 17,751 | 18,861 | 17,442 |
STRIDES PHARMA SCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 601 | 2,048 | 4,814 | -2,578 | 444 | |
From Investments | Rs m | -1,485 | 13,062 | -5,208 | -1,187 | 3,025 | |
From Financial Activity | Rs m | 1,943 | -17,094 | -158 | 4,213 | -2,139 | |
Net Cashflow | Rs m | 1,097 | -1,837 | -564 | 449 | 1,328 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arun Kumar | COMP SEC: Manjula Ramamurthy | YEAR OF INC: 1990 | BSE CODE: 532531 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
Read: STRIDES PHARMA SCIENCE 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare STRIDES PHARMA SCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.